MTI Ltd. in brief
MTI Ltd. is a listed company in the Healthcare sector, based in Japan. Its last known market value was $236 M (March 2026); there is no current figure. In the year to Sep 2020 it had sales of $241 M and a net profit of $4 M, about 2 cents of profit for every dollar of sales. Its shares trade under the symbol 9438.T (Tokyo).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Market cap history
World rank over time
Rank in Japan: #1,318 (Jan 2020) · #1,187 (Jan 2021) · #1,429 (Dec 2022) · #1,512 (Jul 2023) · #1,429 (Jan 2024) · #1,519 (Mar 2026)
Annual results
- Revenue
- $241 M
- Operating income
- —
- Net income
- $4 M
Sep-2020 ending year
Mutual funds holding MTI Ltd.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 International Core Equity 2 PortfolioDimensional Fund Advisors LP | 24,700 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 WisdomTree Japan SmallCap Dividend FundWisdomTree Asset Management, Inc. | 28,100 | $0 M | — | 0.02% | −9.1% | Jun 30, 2026 |
| 🇺🇸 WisdomTree International Equity FundWisdomTree Asset Management, Inc. | 12,100 | $0 M | — | <0.01% | −2.4% | Jun 30, 2026 |
| 🇺🇸 Dimensional International Core Equity 2 ETFDimensional Fund Advisors LP | 9,800 | $0 M | — | <0.01% | −25% | Jul 31, 2026 |
| 🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 3,300 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 5 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
How MTI Ltd. compares in Healthcare
- Revenue$241 M · higher than 53% of 1,795
- Net margin1.7% · higher than 48% of 1,485
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| MTI Ltd.🇯🇵 | $236 M | — | 1.7% | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- UnitedHealth Group Incorporated$367.7 B
- Merck & Co., Inc.$359.8 B
Sources and freshness
- Market cap:
- Mar 8, 2026 (last known)
- Annual results:
- Sep-2020 ending year
- Balance sheet:
- Sep-2020 ending year
- Profile updated:
- Nov 9, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at MTI Ltd.? Verify and update this profile — free
Show MTI Ltd.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.